
Actavis appoints Pepsi head as CFO amid takeover talk
pharmafile | November 14, 2014 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |Â Â Actavis, maria moen, pepsiÂ
Dublin-based speciality pharma firm Actavis which is currently in talks to buy Allergan for $60 billion, has hired a chief financial officer.
Maria Teresa Hilado joins the company on 8 December from PepsiCo where she has served as its senior vice president, finance and treasurer since 2009. Prior to PepsiCo she fulfilled this role at Schering-Plough for a year.
Hilado takes more than 26 years of financial experience to the position and will be based at the company’s US headquarters in New Jersey, and is to succeed R. Todd Joyce, who will remain with Actavis through early 2015 to support the transition.
Brent Saunders, Actavis chief executive and president, says of Hilado: “She will bring extensive expertise in global finance, mergers and acquisitions and business development, and is widely recognised for her exceptional leadership skills. We are excited to add a senior executive of Tessa’s caliber to Actavis.”
Related Content

Patently problematic? The impact of the Eli Lilly/Actavis intellectual property battle
The UK Supreme Court has sent shockwaves through the intellectual property world with its recent …

Gilead to launch injunction against Mylan and Actavis over HIV generics in Ireland
Gilead is expected to launch injunctive action against rivals Mylan and Actavis over the allegation …

Five most talked about mergers and acquisitions of 2016
2017 has kicked off with a bang – as Johnson & Johnson confirmed a $30 …






